The Cigna Group (NYSE:CI) Releases FY25 Earnings Guidance

The Cigna Group (NYSE:CI - Get Free Report) issued an update on its FY25 earnings guidance on Thursday morning. The company provided EPS guidance of $29.50 for the period, compared to the consensus EPS estimate of $29.75.

The Cigna Group Stock Up 0.1 %

Shares of CI traded up $0.22 during trading hours on Thursday, hitting $311.27. The company had a trading volume of 705,066 shares, compared to its average volume of 1,844,211. The company has a market capitalization of $85.19 billion, a PE ratio of 25.40, a price-to-earnings-growth ratio of 0.98 and a beta of 0.53. The company's fifty day moving average price is $295.40 and its two-hundred day moving average price is $317.10. The Cigna Group has a one year low of $262.03 and a one year high of $370.83. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70.

The Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period last year, the firm posted $6.79 earnings per share. As a group, equities analysts forecast that The Cigna Group will post 29.77 earnings per share for the current fiscal year.

The Cigna Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th will be paid a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a yield of 1.94%. This is a boost from The Cigna Group's previous quarterly dividend of $1.40. The ex-dividend date is Wednesday, March 5th. The Cigna Group's dividend payout ratio is 49.35%.

Analyst Ratings Changes

CI has been the subject of several research reports. Piper Sandler reaffirmed an "overweight" rating and issued a $348.00 target price (down from $394.00) on shares of The Cigna Group in a research report on Monday, February 3rd. Cantor Fitzgerald lowered their target price on shares of The Cigna Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research note on Friday, January 31st. Truist Financial decreased their price target on The Cigna Group from $390.00 to $375.00 and set a "buy" rating for the company in a report on Tuesday, February 4th. StockNews.com raised The Cigna Group from a "hold" rating to a "buy" rating in a report on Wednesday, February 19th. Finally, Stephens lowered their target price on The Cigna Group from $410.00 to $380.00 and set an "overweight" rating on the stock in a research note on Friday, January 31st. Two equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average target price of $372.31.

Remove Ads

Insider Activity at The Cigna Group

In other The Cigna Group news, CEO David Cordani sold 26,527 shares of the firm's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the completion of the transaction, the chief executive officer now owns 127,767 shares of the company's stock, valued at approximately $39,367,568.04. This trade represents a 17.19 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Nicole S. Jones sold 4,904 shares of the stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $1,511,020.48. Following the sale, the insider now directly owns 29,421 shares in the company, valued at approximately $9,065,198.52. The trade was a 14.29 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 41,375 shares of company stock valued at $12,866,600 in the last ninety days. Corporate insiders own 0.60% of the company's stock.

Institutional Investors Weigh In On The Cigna Group

An institutional investor recently raised its position in The Cigna Group stock. Brighton Jones LLC boosted its position in The Cigna Group (NYSE:CI - Free Report) by 9.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,736 shares of the health services provider's stock after buying an additional 318 shares during the quarter. Brighton Jones LLC's holdings in The Cigna Group were worth $1,032,000 at the end of the most recent quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.